Cancer

RSS

Hybridon's 1729 for multi-drug-resistant cancers

Nov. 1, 1996

New synthetic process for swainsonine should facilitate clinical testing

Nov. 1, 1996

Hybridon questions role of CAPL in cancer metastasis

Nov. 1, 1996

Low-toxicity antitumor agents described by Ajinomoto

Nov. 1, 1996

Antitumor organotin compounds claimed by Dutch company

Nov. 1, 1996

Peregrine seeks partners for development of vascular targeting agents

Nov. 1, 1996

Cell adhesion inhibitors reported by Sumitomo

Nov. 1, 1996

PDL signs humanized antibody agreement with Japanese company

Nov. 1, 1996

First gene gun clinical trial announced by Auragen

Nov. 1, 1996

HHS claims MAb for therapeutic, diagnostic and immunologic applications

Nov. 1, 1996